A First-in-human, Randomized, Parallel Group, Double-blind, 3-arm Study to Investigate the Comparative PK, Safety, and Tolerability Between Subcutaneous AVT05, US-licensed Simponi®, and EU-approved Simponi® in Healthy Adult Participants
Phase: PHASE1
Conditions: Healthy Adult Subjects
Sponsor: Alvotech Swiss AG

	

   !"#$ $ %
&'()*+")
,&-'
. $ '
/0
&$12.34
5& 1
&"675"")
&"68 ' 
1"9
9
:;:<=>	 ?+.34@%AABB9

C	DEFEG
GF	
2HI33B?)$A3A%9
9